Nomad Power Solutions, Inc. (NMAD): Shareholders' Equity
$9.66M
As of 2025-12-31
$23.91M
As of 2026-06-30
+23.2%
3-year compound annual growth
+14.0%
5-year compound annual growth
+40.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.66M | n/m | 2026-03-31, Balance as of period end |
| 2024-12-31 | $827.2K | -79.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $3.99M | -22.7% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $5.17M | +7.8% | 2024-03-19, Balance as of period end |
| 2021-12-31 | $4.79M | -4.4% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $5.01M | +105.9% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $2.43M | -41.0% | 2021-03-26, Balance as of period end |
| 2018-12-31 | $4.13M | +314.6% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $995.0K | +363.3% | 2019-03-25, Balance as of period end |
| 2016-12-31 | $214.8K | -31.2% | 2018-03-23, Balance as of period end |
| 2015-12-31 | $312.3K | +17.5% | 2017-03-29, Balance as of period end |
| 2014-12-31 | $265.9K | +12.5% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $236.3K | -84.2% | 2015-03-27, Balance as of period end |
| 2012-12-31 | $1.49M | n/m | 2014-03-21, Balance as of period end |
| 2011-12-31 | $79.0K | -95.4% | 2014-03-21, Balance as of period end |
| 2010-12-31 | $1.74M | +33.4% | 2014-03-21, Balance as of period end |
| 2009-12-31 | $1.30M | n/m | 2014-03-21, Balance as of period end |
| 2008-12-31 | -$323.5K | n/m | 2014-03-21, Balance as of period end |
| 2007-12-31 | $376.9K | -31.8% | 2014-03-21, Balance as of period end |
| 2006-12-31 | $552.6K | n/m | 2014-03-21, Balance as of period end |
| 2005-12-31 | -$14.6K | n/a | 2014-03-21, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $9.66M | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $9.40M | -32.4% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$15.94M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | $7.06M | +66.4% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $4.69M | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $11.66M | +205.8% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $12.45M | +528.5% |
Compare NMAD, PPCB, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗